The document also adds that the proposed changes by the WHO could give people the wrong idea, leading them to think that the current Schedule IV stance impedes research and that the international framework isn’t compatible with research. What they’re basically saying is that even if the United States acknowledges the benefits of reclassifying cannabis, the government is worried about how it would turn out.
Republican Senators James Lankford (Oklahoma) and Pete Ricketts (Nebraska) have introduced a bill that seeks…
New blue hues and flavors from top breeders have arrived. The post New Blueberry weed…
While there are many studies showing potential and promise for using various compounds in cannabis…
Trump's declaration of drug cartels as terrorist organizations and his war cry to ramp up…
A recent poll conducted by the University of Houston’s Hobby School of Public Affairs has…
Candies, Z, OGs, and more from Leafly’s senior editor. The post David Downs’ sickest weed…